Topotecan Active Not Recruiting Phase 1 Trials for Tumors, Solid / Recurrent Childhood Cerebral Astrocytoma / Unspecified Adult Solid Tumor, Protocol Specific / Recurrent Extragonadal Germ Cell Tumor / Childhood Central Nervous System Germ Cell Tumor / Recurrent Childhood Medulloblastoma / Recurrent Childhood Cerebellar Astrocytoma / Unspecified Childhood Solid Tumor, Protocol Specific / Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor / Recurrent Malignant Testicular Germ Cell Tumor / Recurrent Adult Soft Tissue Sarcoma / Recurrent Childhood Pineoblastoma / Recurrent Neuroblastoma / Recurrent Childhood Malignant Germ Cell Tumor / Recurrent Adult Brain Tumor / Childhood Soft Tissue Sarcoma / Ovarian Mixed Germ Cell Tumor / Recurrent Childhood Visual Pathway Glioma / Recurrent Ovarian Germ Cell Tumor / Recurrent Childhood Ependymoma / Adult Rhabdomyosarcoma / Recurrent Childhood Visual Pathway and Hypothalamic Glioma / Adult Central Nervous System Germ Cell Tumor / Recurrent Childhood Brain Stem Glioma / Recurrent Extragonadal Non-seminomatous Germ Cell Tumor / Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor / Previously Untreated Childhood Rhabdomyosarcoma / Recurrent Wilms Tumor and Other Childhood Kidney Tumors / Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor / Ewing's Sarcoma (ES) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00638898Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor